U.S., Norway pledge $150 million for maternal health
OSLO (Reuters) - The United States and Norway each pledged on Friday to give in the range of $75 million to help protect mothers during labor, delivery and the first 24 hours after birth.
The money would go into the "Saving Mothers, Giving Life," initiative, a partnership financed with public and private funds that seeks to reduce the death of mothers immediately before, during and soon after they give birth.
Recalling the 1980 birth of her daughter, Chelsea, U.S. Secretary of State Hillary Clinton mused about how she would have felt had she not had a healthcare facility with skilled doctors and nurses and the equipment and expertise to handle emergencies.
"How fortunate I was. But surviving childbirth and growing up healthy should not be a matter of luck or where you live or how much money you have. It should be a fact for every woman everywhere," Clinton said as she announced the $75 million U.S. contribution at a health conference in Norway.
A U.S. official said $60 million had already been approved by the U.S. Congress, and the other $15 million was part of the Obama administration's budget request for the year beginning October 1.
At the same conference, Norwegian Foreign Minister Jonas Gahr said Norway would devote up to about $80 million to the effort, whose partners include drug maker Merck & Co and nonprofit Every Mother Counts.
Norway's pledge is also subject to parliamentary approval.
Rather than focusing on a single step to reduce maternal mortality, Clinton said the aim was to strengthen health systems more generally, saying the existence of 24-hour clinics, the availability of skilled doctors, nurses and midwives and the reliability of transportation networks all play a role.
(Reporting by Arshad Mohammed; Editing by Peter Cooney)
- Tweet this
- Share this
- Digg this
- UPDATE 3-Pizza chain Sbarro files for bankruptcy protection
- U.S. top court declines to hear 'I (heart sign) boobies' case
- Ten countries scour sea for Malaysia jet lost in "unprecedented mystery"
- Evidence so far does not point to attack on Malaysian plane - sources
- Allianz lead insurer and Willis broker for Malaysia Airlines
The therapy is one of several new blood clotting agents in development that will help hemophilia patients cut by half, or more, the number of regular intravenous infusions they need to prevent traumatic bleeding. People with hemophilia have a fault in a gene that regulates the body's production of proteins called clotting factors. Full Article